NCT01543529 A Pharmacodynamic and Pharmacokinetic Study of RO4917838 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01543503 An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT01535729 An Observational Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase N/A
NCT01532869 A Study of RoActemra/Actemra (Tocilizumab) Versus Placebo in Patients With Systemic Sclerosis Status COMPLETED Phase PHASE3
NCT01531647 A Study of Drug-Drug Interaction Between Danoprevir/Low-Dose Ritonavir and Raltegravir in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01524978 A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers Status COMPLETED Phase PHASE2
NCT01519960 A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B Status COMPLETED Phase PHASE3
NCT01519947 A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or Dialysis Status COMPLETED Phase PHASE4
NCT01519921 A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B. Status COMPLETED Phase PHASE4
NCT01519336 A Study of Drug-Drug Interaction Between Darunavir and Danoprevir Administered Together With Low-Dose Ritonavir in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01519323 BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations Status TERMINATED Phase PHASE1
NCT01516541 A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease Status COMPLETED Phase PHASE3
NCT01516476 Study of RO6807952 in Patients With Diabetes Mellitus Type 2 Status TERMINATED Phase PHASE2
NCT01514968 A Drug-Drug Interaction Study Between Danoprevir/Low-Dose Ritonavir and Cyclosporine in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01513083 A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function Status COMPLETED Phase PHASE1
NCT01512420 An Observational Study of Tarceva (Erlotinib) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With Wild-Type Epidermal Growth Factor Receptor (EGFR) Gene (WILT) Status COMPLETED Phase N/A
NCT01510899 A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838 Status COMPLETED Phase PHASE1
NCT01508130 An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1 Status COMPLETED Phase N/A
NCT01507168 A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma Status COMPLETED Phase PHASE2